Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-blocker Effect on Structural Remodeling and Gene Expression in the Failing Human Heart

NCT01798992 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01798992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01798992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-blocker Effect on Structural Remodeling and Gene Expression in the Failing Human Heart
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2000
Completion date
March 31, 2009
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic dilated cardiomyopathy